Log In
Print
BCIQ
Print
Print this Print this
 

Feraheme, Rienso, ferumoxytol

Also known as: formerly Code 7228

  Manage Alerts
Collapse Summary General Information
Company AMAG Pharmaceuticals Inc.
DescriptionIV iron replacement therapy
Molecular Target Not applicable
Mechanism of ActionNA
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat adult iron deficiency anemia (IDA) patients who have failed oral iron treament; Treat iron deficiency anemia in adult patients who have failed or otherwise cannot take oral iron therapy; Treat iron deficiency anemia in patients with chronic kidney disease (CKD)
Regulatory Designation

Partner

3SBio Inc.; Takeda Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today